The Clearly Congruent Canine Compedium, page-22

do you know the expense? do you or we even know their costs going forward? they keep referring to backward looking cash burn run rates.
it is less about exposure than it is a valuation that the market place over there puts on bio assets and if they attract the correct dedicated shareholders the exposure comes as a natural follow on.
the largest pool of dedicated healthcare funds is not in australia.
the milestones that have been kicked off so far, have done what to the valuation the market assigns?
planning a usa listing in no way gets in the road of trials.
the point made about having the time to focus on this is valid, given how stretched the chairperson & md would be and the cfo, as both have obligations elsewhere.